Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects

European Journal of Clinical Investigation

Volumn 27, Issue 4, 1997, Pages 270-276

  Steele, I C ^a   McDowell, G ^a   Moore, A ^a   Campbell, N P S ^a   Shaw, C ^a   Buchanan, K D ^a   Nicholls, D P ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Chronic heart failure; Exercise; Ventricular ejection fractions

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; HEART FAILURE; HEART FUNCTION; HUMAN; PRIORITY JOURNAL;

EID: 0030947085     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1070653.x     Document Type: Article

References (47)

1. Henry JP, Pearse JW. The possible role of cardiac atrial stress receptors in the induction of changes in urine blood flow. J Physiol 1956;131:572-85.
2. de Wardener HE. Natriuretic hormone. Clin Sci Mol Med 1977; 53:1-8.
3. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
4. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 1985;314:264-6.
5. Brenner BM, Ballerman BJ, Gunning ME, Zeidel ML. Diverse biological actions of ANP. Physiol Rev 1990;70:665-99.
6. ++ effects in normal man. J Clin Invest 1987;80:832-40.
7. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988;62:191-5.
8. Burnett JC, Kao PC, Hu DC et al. Atrial natriuretic peptide elevation in congestive heart failure. Science 1986;231:1145-7.
9. Pettersson A, Hedner J, Hedner T, Held P, Swedberg K, Towle AC. Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. Eur Heart J 1986;7:693-6.
10. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
11. Mukoyama M, Nakao K, Hosoda K et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
12. Yoshimura M, Yasue H, Morita E et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581-8.
13. Lang CC, Motwani JG, Coutie WJR, Struthers AD. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. Clin Sci 1992;82:619-23.
14. Omland T, Aakvaag A, Bonarjee VVS et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
15. Onuoha GN, Shaw C, Nugent A-M et al. Brain and atrial natriuretic peptides during exercise. Eur Heart J 1994;15(abstract suppl.):552.
16. Brown JM, White CJ, Sobol SM, Lull RJ. Increased left ventricular ejection fraction after a meal: potential source of error in performance of radionuclide angiography. Am J Cardiol 1983; 51:1709-11.
17. Riley M, Northridge DB, Henderson E, Stanford CF, Nicholls DP, Dargie HJ. The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J 1992;13:1363-7.
18. Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, Nicholls DP. Resting energy expenditure in chronic cardiac failure. Clin Sci 1991;80:633-9.
19. Borg GAV. Psychophysical bases for perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
20. Lacy JL, LeBlanc AD, Babich JW et al. A gamma camera for medical applications using a proportional counter. J Nucl Med 1984;25:1003-12.
21. Lacy JL, Ball ME, Verani MS et al. An improved Tungsten-178/ Tantalum-178 generator system for high volume clinical applications. J Nucl Med 1988;29:1526-38.
22. Vallely SR, Campbell NPS, Laird JD, Ferguson R, Anderson C, Radionuclide angiography using a multiwire camera and Tantalum-178 (Ta-178) - an advance over conventional imaging techniques. Eur Heart J 1992;13(abstract suppl.):144.
23. Cleland JGF, Ward S, Dutka D, Habib F, Impallomeni M, Morton IJ. Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature. Heart 1996;75:410-13.
24. Nugent AM, Onuoha GN, McEneaney DJ et al. Variable patterns of atrial natriuretic peptide secretion in man. Eur J Clin Invest 1994;24:267-74.
25. Pogashi K, Hirata Y, Ando K, Taku Y, Kawakami M, Marumo F. Brain natriuretic peptide-like immunoreactivity is present in human plasma. FEBS Lett 1989;250:235-7.
26. Packer M, Medina N, Yushak M. Haemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterisation in patients with chronic heart failure. Circulation 1985;71:761-6.
27. Anonymous. Complications of pulmonary artery balloon flotation catheters. Lancet 1983;i:37-8.
28. Weber KT, Kimisewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic-cardiac failure. Circulation 1982;65:1213-23.
29. Nicholls DP, Riley M, Elborn JS, Stanford CF, Shaw C, McKillop JM, Buchanan KD. Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exercise. Eur Heart J 1992;13:1399-404.
30. Keller N, Larsen J, Sykulski R, Storm T, Thamsborg G. Atrial natriuretic factor during exercise in patients with congestive heart failure. Acta Endocrinol 1988;118:168-72.
31. Pfisterer MA, Battler A, Zaret BL. Range of normal values for left and right ventricular ejection fraction at rest and during exercise assessed by radionuclide angiography. Eur Heart J 1985;6:647-55.
32. Port S, Cobb FR, Coleman RE, Jones RH. Effect of age on the response of the left ventricular ejection fraction to exercise. N Engl J Med 1980;303:1133-7.
33. Schocken DD, Blumenthal JA, Port S, Hindle P, Coleman RE. Physical conditioning and left ventricular performance in the elderly: assessment by radionuclide angiocardiography. Am J Cardiol 1983;52:359-64.
34. Davis M, Espiner E, Richards G et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994,343:440-4.
35. Struthers AD. Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? Br Heart J 1993;70:397-8.
36. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993;341: 1109-13.
37. McDonough JR, Danielson RA, Wills RE, Vine DL. Maximal cardiac output during exercise in patients with coronary artery disease. Am J Cardiol 1974;33:23-9.
38. Nugent AM, McParland J, McEneaney DJ, Steele I, Campbell NPS, Stanford CF, Nicholls DP. Non-invasive measurement of cardiac-output by a carbon dioxide rebreathing method at rest and during exercise. Eur Heart J 1994;15:361-8.
39. Steele IC, Moore A, Nugent AM, Campbell NPS, Nicholls DP. Cardiac output during exercise in chronic cardiac failure. Clin Sci 1995;87:19P.
40. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
41. Thibault G, Garcia R, Gutkowska J et al. The propeptide Asn 1-Tyr 126 is the storage form of rat atrial natriuretic factor. Biochem J 1987;241:265-72.
42. Hosoda K, Nakao K, Mukoyama M et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991;17:1152-5.
43. Hashimoto Y, Nakao K, Hama N et al. Clearance mechanisms of atrial and brain natriuretic peptides in rats. Pharm Res 1994;11: 60-4.
44. Yoshimura M, Yasue H, Morita E et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581-8.
45. Matsumoto A, Hirata Y, Momomura S et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 1995;129: 139-45.
46. Lang CC, Prasad N, McAlpine HM, MacLeod C, Lipworth BJ, MacDonald TM, Struthers AD. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994;127:1635-6.
47. Grossman W. Diastolic dysfunction and congestive heart failure. Circulation 1990;81(suppl. III):III1-III7.